Author Question: After hospital discharge, a priority intervention that should be planned for a family and the client ... (Read 79 times)

daltonest1984

  • Hero Member
  • *****
  • Posts: 536
After hospital discharge, a priority intervention that should be planned for a family and the client
  with bipolar disorder who is taking antimanic medication is
 
  a. decreasing physical activity.
  b. increasing food and fluids.
  c. meeting self-care needs.
  d. psychoeducation.

Question 2

The nurse caring for a client taking SSRIs will develop evaluation parameters and outcome criteria
  related to
 
  a. mood improvement.
  b. logical thought processes.
  c. reduced levels of motor activity.
  d. increased extrapyramidal symptoms.



smrtceo

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

D
Options A, B, and C: During the continuation phase of treatment for bipolar disorder, the physical
needs of the client are not as important an issue as they were during the acute episode. After hospital
discharge, treatment focuses on maintaining medication compliance and preventing relapse, both of
which are fostered by ongoing psychoeducation.

Answer to Question 2

ANS: A
SSRIs affect mood, relieving depression in many cases. Option B: SSRIs do not act to reduce
thought disorders. Option C: SSRIs reduce depression but have little effect on motor hyperactivity.
Option D: SSRIs do not produce extrapyramidal symptoms.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

People with high total cholesterol have about two times the risk for heart disease as people with ideal levels.

Did you know?

The average human gut is home to perhaps 500 to 1,000 different species of bacteria.

Did you know?

According to the National Institute of Environmental Health Sciences, lung disease is the third leading killer in the United States, responsible for one in seven deaths. It is the leading cause of death among infants under the age of one year.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

For a complete list of videos, visit our video library